PSMA-PET total tumour volume is prognostic for overall survival in mCRPC. thelancet.com/journals/lanon… PSMA-PET value extends beyond selection for PSMA-RLT therapy in metastatic prostate cancer. urotoday.com/video-lectures… ANZUP @trialscentre Prostate Cancer Foundation Movember Australia

Third LancetOncology paper to come out of the ANZUP #ENZAp #ProstateCancer #pcsm #ClinicalTrial - congratulations Louise Emmett and grateful thanks to all investigators, research teams, and of course the participants who have helped move the whole field ahead.

Excellent session titled “Beyond the Scope: Noninvasive Monitoring in Bladder Cancer”, chaired by Keyan Salari and Kristen R. Scarpato at #BCANTT25! Grateful for the opportunity to present our lab’s work here. Pradeep Chauhan Mayo Clinic Radiation Oncology Bladder Cancer Advocacy Network

Prostate Imaging for Recurrence Reporting: User Guide pubs.rsna.org/doi/10.1148/rg… The Prostate Imaging for Recurrence Reporting (PI-RR) system, introduced in 2021, provides a standardized framework for interpreting pelvic MRI in patients with suspected #ProstateCancer recurrence

Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant prostate cancer in ENZA-p (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial - The Lancet Oncology thelancet.com/journals/lanon…

Congratulations to Nepean Hospital on 2,000 robotic surgeries – a major milestone in Australian Urology. From NSW’s first public Da Vinci robot to an international training centre,Particular congratulations to the Urology team and USANZ Members listed here bit.ly/Nepean2000

The FDA has granted regenerative medicine advanced therapy designation to GLPG5101, a second-generation anti-CD19/4-1BB CAR-T product candidate, for the treatment of patients with relapsed/refractory mantle cell lymphoma. #lymsm #CART #oncology hubs.li/Q03BRVVF0

ICER #WeeklyView: ICER’s Patient Council, RFK Jr. cancels $500M mRNA vaccine contracts, & CMMI to experiment with weight loss Rx coverage: conta.cc/451WXiC

Happy Saturday. Vinay Prasad returns to the FDA, weeks after his ouster | STAT statnews.com/2025/08/09/vin…

Vinay Prasad MD MPH is back, things are in order. The U.S. FDA must remain free from undue influence, to protect populations and patients! Huge congratulations to Secretary Kennedy and Dr. Marty Makary for their great leadership. Welcome back Vinay, my friend! Recess is over – now the real work

And just like that, Vinay Prasad is back at the helm of CBER. From the convos I've been having, it's safe to say that no one in biotech understands which end is up at the FDA. The agency included a swipe at "the fake news" in making the announcement. But a simple chronology of

FDA 🔥 🔥 🔥

Special report: Most expensive drugs in the US in 2025 fiercepharma.com/special-report…

New #osteosarcoma therapies needed NOW. FDA & The Osteosarcoma Institute convening stakeholders Oct 10 to identify barriers, increase trial efficiency & advance innovative designs. Join the conversation that could change outcomes! fda.gov/news-events/fd… #RareDiseaseResearch

Join experts from FDA, academia, industry & advocacy on Sept 11 for the FDA-AACR Workshop: Approach to Novel Oncology Endpoint Development. •In-person: myaacr.aacr.org/LiveEventsList… •Virtual: myaacr.aacr.org/LiveEventsList…

In this episode of "The Top Line," we break down the latest Most Favored Nation pricing pressures in the U.S., how companies are responding and which facets of the proposal might fall short of Trump’s goals. fiercepharma.com/pharma/trumps-…

🧬 Sydney is leading biomaterials innovation, driven by world-class research, top universities & visionary companies. Vow and Inventia Life Science are making big strides in bioprinting and cell modelling. Learn more 🔗 hello.besydney.com.au/l/315211/2025-… #MeetInSydney

The Independent Health and Aged Care Pricing Authority (IHACPA) is seeking your feedback to help them advise the government on residential aged care pricing and costing. Submit your feedback on IHACPA’s engagement hub by 22 August 💻 engage.ihacpa.gov.au/pfaacs/pricing…

Tuesday is "Treat or Trigger" Day!  Today's topic is STRESS. It might trigger an attack, while others may thrive on high energy levels. Everyone experiences migraine differently - how does stress affect you? #TreatOrTrigger #migraineaustralia #migrainesupport

We are excited to announce the first #AusPainSoc #BPRSIG #PainHour for 2025! Scheduled for Thurs 21AUG25 at 12-1pm AEST via Zoom. Register here: ow.ly/4WYL50Wx6FB Places are limited; see you there!